These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 6138376
1. Nadolol and supraventricular tachycardia: an electrophysiologic study. Chang MS, Sung RJ, Tai TY, Lin SL, Liu PH, Chiang BN. J Am Coll Cardiol; 1983 Nov; 2(5):894-903. PubMed ID: 6138376 [Abstract] [Full Text] [Related]
2. Electrophysiologic effects, clinical efficacy and safety of intravenous and oral nadolol in refractory supraventricular tachyarrhythmias. Saksena S, Klein GJ, Kowey PR, Calvo RA, Boccadamo R, Brown JE, Sharma AD, Gadhoke A, Olukotun AY. Am J Cardiol; 1987 Feb 01; 59(4):307-12. PubMed ID: 3812280 [Abstract] [Full Text] [Related]
3. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia. Lai WT, Voon WC, Yen HW, Chang JS, Sheu SH, Hwang YS, Chiu HF. Am J Cardiol; 1993 Feb 15; 71(5):405-8. PubMed ID: 8430627 [Abstract] [Full Text] [Related]
4. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia. Manz M, Steinbeck G, Lüderitz B. Am J Cardiol; 1985 Oct 01; 56(10):593-7. PubMed ID: 4050693 [Abstract] [Full Text] [Related]
5. Role of intravenous isoproterenol in the electrophysiologic induction of atrioventricular node reentrant tachycardia in patients with dual atrioventricular node pathways. Huycke EC, Lai WT, Nguyen NX, Keung EC, Sung RJ. Am J Cardiol; 1989 Nov 15; 64(18):1131-7. PubMed ID: 2479251 [Abstract] [Full Text] [Related]
6. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia]. Kühlkamp V, Ickrath O, Schmid F, Mayer F, Haasis R, Seipel L. Z Kardiol; 1989 Oct 15; 78(10):640-6. PubMed ID: 2686251 [Abstract] [Full Text] [Related]
7. [Electrophysiologic effects of betaxolol on conduction properties of the antegrade and retrograde pathway in patients with typical atrioventricular node reentry tachycardia following intravenous and oral administration]. Kühlkamp V, Ickrath O, Haasis R, Seipel L. Z Kardiol; 1988 Aug 15; 77(8):527-33. PubMed ID: 3176596 [Abstract] [Full Text] [Related]
8. Interactions of esmolol and adenosine in atrioventricular nodal-dependent supraventricular tachycardia: implication for the cellular mechanisms of adenosine. Chang KC, Lin YC, Chen JY, Chou HT, Hung JS. Cardiology; 2002 Aug 15; 97(3):138-46. PubMed ID: 12077566 [Abstract] [Full Text] [Related]
9. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate. Kim SS, Lal R, Ruffy R. Am J Cardiol; 1986 Jul 01; 58(1):80-5. PubMed ID: 3728336 [Abstract] [Full Text] [Related]
10. Sustained symptomatic sinus node reentrant tachycardia: incidence, clinical significance, electrophysiologic observations and the effects of antiarrhythmic agents. Gomes JA, Hariman RJ, Kang PS, Chowdry IH. J Am Coll Cardiol; 1985 Jan 01; 5(1):45-57. PubMed ID: 3964808 [Abstract] [Full Text] [Related]
11. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia. Gambhir DS, Bhargava M, Nair M, Arora R, Khalilullah M. Indian Heart J; 1996 Jan 01; 48(2):133-7. PubMed ID: 8682552 [Abstract] [Full Text] [Related]
12. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias. Hellestrand KJ, Nathan AW, Bexton RS, Spurrell RA, Camm AJ. Am J Cardiol; 1983 Mar 01; 51(5):770-6. PubMed ID: 6829436 [Abstract] [Full Text] [Related]
13. Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia. Hoff PI, Tronstad A, Oie B, Ohm OJ. Am J Cardiol; 1988 Sep 15; 62(9):585-9. PubMed ID: 3137798 [Abstract] [Full Text] [Related]
14. Electrophysiologic effects and antiarrhythmic efficacy of recainam in patients with supraventricular tachycardia. Tai YT, Campbell RW, McComb JM. J Cardiovasc Pharmacol; 1991 Feb 15; 17(2):310-5. PubMed ID: 1709237 [Abstract] [Full Text] [Related]
15. [Cibenzoline: electrophysiologic effects of a new class I anti-arrhythmia agents in supraventricular tachycardia]. Pfitzner P, Manz M, Schütz R, Lüderitz B. Z Kardiol; 1989 Oct 15; 78(10):654-60. PubMed ID: 2686252 [Abstract] [Full Text] [Related]
16. Metoprolol in the treatment and prophylaxis of paroxysmal reentrant supraventricular tachycardia. Gmeiner R, Ng CK. J Cardiovasc Pharmacol; 1982 Oct 15; 4(1):5-13. PubMed ID: 6176799 [Abstract] [Full Text] [Related]
17. Electrophysiologic and antiarrhythmic effects of oral encainide in patients with atrioventricular nodal reentry or nodoventricular reentry. Miles WM, Chang MS, Heger JJ, Rinkenberger RL, Zipes DP, Prystowsky EN. Am Heart J; 1987 Jul 15; 114(1 Pt 1):26-33. PubMed ID: 3111237 [Abstract] [Full Text] [Related]
18. [Effectiveness and pharmacodynamics of tobanum in patients with paroxysmal reciprocal atrioventricular tachycardia]. Grosu AA, Zhosan SI. Kardiologiia; 1991 Jul 15; 31(7):45-7. PubMed ID: 1685755 [Abstract] [Full Text] [Related]
19. Comparison of the effects of intravenous and oral betaxolol on antegrade and retrograde conduction in patients with atrioventricular nodal reentrant and atrioventricular reentrant tachycardia. Kühlkamp V, Ickrath O, Haasis R, Seipel L. Eur Heart J; 1989 Jun 15; 10(6):493-501. PubMed ID: 2569398 [Abstract] [Full Text] [Related]
20. Combined verapamil and propranolol for supraventricular tachycardia. Yee R, Gulamhusein SS, Klein GJ. Am J Cardiol; 1984 Mar 01; 53(6):757-63. PubMed ID: 6702624 [Abstract] [Full Text] [Related] Page: [Next] [New Search]